Skip to content

Clinical trials

Phase 1 Neuralgia trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neuralgia Phase: Phase 1 Country / region: United States Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20141
20151
20161
20181
20193
20203
20231
20252
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Not yet recruiting3
Recruiting2
Unknown status2
Enrolling by invitation1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Stanford University3
4E Therapeutics1
Afasci Inc1
Alcamena Stem Cell Therapeutics1
Biogen1
Biohaven Therapeutics Ltd.1
Brigham and Women's Hospital1
Children's Hospital of Michigan1
Contineum Therapeutics1
EicOsis Human Health Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neuralgia20
Chronic Pain4
Pain4
Nociceptive Pain3
Radiculopathy2
Spinal Cord Injuries2
Agnosia1
Anemia, Sickle Cell1
Channelopathies1
Dry Eye Syndromes1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.